---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-020126"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2024-02-26T23:59:59+00:00"
generated_at: "2026-06-05T16:00:05.294247+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical Q4 net sales up 19% to $76.3M; ICL sales +22%; FY2024 outlook $335-340M

## Summary
- Q4 net sales $76.3M (+19% YoY), ICL sales $74.6M (+22%), ICL units +19%.
- Q4 net income $7.8M ($0.16 EPS) vs $6.8M ($0.14 EPS); gross margin 79.6% vs 77.7%.
- FY2023 net sales $322.4M (+13%), net income $21.3M ($0.43 EPS) vs $39.7M ($0.80 EPS).
- Cash, cash equivalents and investments $232.4M, no debt; FY2024 net sales outlook $335-340M.
- China ICL sales grew 30% in Q4; EMEA up 18%; company affirms FY2024 sales outlook.

## SEC filing metadata
- accession: 0000950170-24-020126
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2024-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/0000950170-24-020126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/staa-20240226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-020126
- JSON: https://secwatch.observer/filing/0000950170-24-020126.json
- Plain text: https://secwatch.observer/filing/0000950170-24-020126.txt

## Key facts
- Earnings Releases
  STAAR SURGICAL CO updated its the quarter and year ended December 29, 2023 guidance (reaffirmed).
  - Period: the quarter and year ended December 29, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 26, 2024, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter and year ended December 29, 2023, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/0000950170-24-020126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.